Dysarthria

FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia

...ia. Too rapid correction of hyponatremia (e.g., increase greater than 12 mEq/L/24 hours) can cause osmotic demyelination syndrome (ODS), resulting in dysarthria (difficulty speaking), mutism, dysphagia (trouble swallowing), lethargy, affective changes (mood changes), spastic quadraparesis (involuntary muscle w...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

...ziness (10%-13% vs. 4%-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6%-7% vs. 2%-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%). The most commonly reported adverse reactions associated with the use of SEROQUEL vs. placebo in clini...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

...ziness (10%-13% vs. 4%-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6%-7% vs. 2%-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%). The most commonly reported adverse reactions associated with the use of SEROQUEL vs. placebo in clini...

FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site

... dizziness (10-13% vs. 4-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6-7% vs. 2-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%). Please see full Prescribing Information, including Boxed Warnings, for SEROQUEL XR. ...

AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression

... dizziness (10-13% vs. 4-11%), orthostatic hypotension (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6-7% vs. 2-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%). Please see full Prescribing Information, including Boxed Warnings, for SEROQUEL XR. ...

Another Use For Epilepsy Drugs

...atients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation. ...

Epileptic Drug Found To Be Effective In Relieving Headache

...atients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation. ...

Epilepsy Drug May Relieve Chronic Headaches

...atients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation. ...

Dysarthria in Medical Technology

Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy

...with retigabine in the RESTORE trials occurring in greater than or equal to 10 percent of patients included dizziness, somnolence, fatigue, confusion, dysarthria (slurred speech), ataxia (loss of muscle coordination), urinary tract infection, blurred vision, tremor, and nausea. Urinary bladder effects, while mo...

Dysarthria in Medical Dictionary

Dysarthria

Dysarthria is a motor speech disorder resulting from neurological injury, characterised by poor articulation . Any of the speech subsystems can be affected. The resulting speech condition is called dysarthria . ... for people with dysarthria ? What can I do to communicate better with a pers...

Speech disorders

...ent of children have noticeable speech disorders . ... ... 20 disease causes of Speech disorders , patient stories, diagnostic guides, ... dysarthria AND SPEECH DISORDERS (Differential Diagnosis in Primary Care) ... Speech Disorders - Get medical information on Speech Disorders in He...

Dysarthria in Biological Technology

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

...dizziness (10% vs. 4%), constipation (10% vs. 3%), weight gain (7% vs. 1%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%).(5) Important Safety Inform...gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6-7% vs. 2-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. 1%). In long-term clinical tria...